
Omalizumab updosing allows disease activity control in refractory patients with chronic spontaneous urticaria
Curto-Barredo, L., Spertino, J., Figueras-Nart, I., Expósito-Serrano, V., Guilabert, A., Melé-Ninot, G., Cubiró, X., Bonfill-Ortí, M., Garcias-Ladaria, J., Villar, M., García-Navarro, X., Bielsa-MarsoLangue:
english
Journal:
British Journal of Dermatology
DOI:
10.1111/bjd.16379
Date:
January, 2018
Fichier:
PDF, 470 KB
english, 2018